Arcoma wins tender of 10 million SEK to Czech Republic
2022-09-26 PRESSRELEASE Arcoma wins tender of 10 million SEK to Czech Republic Arcoma AB has won a tender of 5 Arcoma Precision i5 systems to “Prague...
Source: globenewswire.com
Page 33 - Nasdaq First News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq First. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq First Today - Breaking & Trending Today
Investegate |Faron Pharma. Oy Announcements | Faron Pharma. Oy: Grant of Options
Investegate announcements from Faron Pharma. Oy, Grant of Options
Source: investegate.co.uk
Onxeo S.A.: Onxeo Reports its Half-Year 2022 Financial Results and Provides an Update on its Activities
> Refocusing R&D efforts as well as accelerating preclinical and clinical programs globally > Cash position of €26.9 million as of June 30, 2022 > Financial visibility assured until Q2 2023 Regulatory
Source: finanznachrichten.de
High-Grade Glioma Relapse in Children: Onxeo Announces the Enrollment of the First Patient in the Ph
PARIS--(BUSINESS WIRE)--Regulatory News:Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North1: ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR)n in particular against rare or resistant forms of cancer, today announced that...
Source: pharmiweb.com
Onxeo S.A.: High-Grade Glioma Relapse in Children: Onxeo Announces the Enrollment of the First Patient in the Phase 1b/2 Clinical Study Conducted by the European ITCC Consortium and Sponsored by Institut Curie
Regulatory News: Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North1: ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage
Source: finanznachrichten.de